Oral oncolytics

Oral oncolytics: imatinib, pazopanib, sunitinib and desethylsunitinib in serum. A clinical case is presented with the fourth vial to test the clinical advisory skills of the laboratory.

Frequency

4 rounds of 1 samples

Number of participants

19

Price

Participation
€ 443.97
Additional sample set
€ 206.31
Additional cluster
€ 131.49

Details

Report

This scheme is processed and reported electronically (QBase).

Supported analytes

Cabozantinib
Desethylsunitinib
Imatinib
Olaparib
Pazopanib
Sunitinib

Methodelijst Orale oncolytica

CabozantinibConsensus methodegroep
HPLC-MS/UPLC-MS/MS-detectie MS-detectie
HPLC-UV Overige methodes
Overigen Overige methodes
DesethylsunitinibConsensus methodegroep
HPLC-MS/UPLC-MS/MS-detectie MS-detectie
HPLC-UV Overige methodes
Overigen Overige methodes
ImatinibConsensus methodegroep
HPLC-MS/UPLC-MS/MS-detectie MS-detectie
HPLC-UV Overige methodes
Overigen Overige methodes
OlaparibConsensus methodegroep
HPLC-MS/UPLC-MS/MS-detectie MS-detectie
HPLC-UV Overige methodes
Overigen Overige methodes
PazopanibConsensus methodegroep
HPLC-MS/UPLC-MS/MS-detectie MS-detectie
HPLC-UV Overige methodes
SunitinibConsensus methodegroep
HPLC-MS/UPLC-MS/MS-detectie MS-detectie
HPLC-UV Overige methodes

Questions about this scheme?

Use the form below to send us a message.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.